Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

This study is currently recruiting participants.

Study NCT00041613 Information provided by Introgen Therapeutics

First Received: July 11, 2002 Last Updated: March 28, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given